| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)
|
OHIRA, T.
|
|
2007
|
5 |
7 |
p. 1455-1461
|
artikel
|
| 2 |
Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins
|
KELLER, T. T.
|
|
2007
|
5 |
7 |
p. 1567-1569
|
artikel
|
| 3 |
ANNOUNCEMENTS
|
|
|
2007
|
5 |
7 |
p. 1573
|
artikel
|
| 4 |
A proposed structural model of human protein Z
|
LEE, C. J.
|
|
2007
|
5 |
7 |
p. 1558-1561
|
artikel
|
| 5 |
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery
|
QUINLAN, D. J.
|
|
2007
|
5 |
7 |
p. 1438-1443
|
artikel
|
| 6 |
Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis
|
VAN HYLCKAMA VLIEG, A.
|
|
2007
|
5 |
7 |
p. 1449-1454
|
artikel
|
| 7 |
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients
|
DIELIS, A. W. J. H.
|
|
2007
|
5 |
7 |
p. 1509-1515
|
artikel
|
| 8 |
Clearance mechanisms of von Willebrand factor and factor VIII
|
LENTING, P. J.
|
|
2007
|
5 |
7 |
p. 1353-1360
|
artikel
|
| 9 |
Controlled shedding of platelet glycoprotein (GP)VI and GPIb–IX–V by ADAM family metalloproteinases
|
GARDINER, E. E.
|
|
2007
|
5 |
7 |
p. 1530-1537
|
artikel
|
| 10 |
Endothelial protein C receptor: location…with a pool!
|
WEILER, H.
|
|
2007
|
5 |
7 |
p. 1391-1393
|
artikel
|
| 11 |
Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin
|
FORTENBERRY, Y. M.
|
|
2007
|
5 |
7 |
p. 1486-1492
|
artikel
|
| 12 |
Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development
|
REPESSÉ, Y.
|
|
2007
|
5 |
7 |
p. 1469-1476
|
artikel
|
| 13 |
Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications
|
BAJAJ, M. S.
|
|
2007
|
5 |
7 |
p. 1493-1499
|
artikel
|
| 14 |
High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes 1
|
HOVENS, M. M. C.
|
|
2007
|
5 |
7 |
p. 1562-1564
|
artikel
|
| 15 |
Inhibitors, what is the risk of treatment intensity?
|
COLLINS, P. W.
|
|
2007
|
5 |
7 |
p. 1380-1382
|
artikel
|
| 16 |
Is tissue factor the ‘original sin’ of clotting, or is it factor VII?
|
RICKLES, F. R.
|
|
2007
|
5 |
7 |
p. 1401-1402
|
artikel
|
| 17 |
Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?
|
NAPOLEONE, E.
|
|
2007
|
5 |
7 |
p. 1462-1468
|
artikel
|
| 18 |
Mechanical prophylaxis for travellers’ thrombosis: a comparison of three interventions that promote venous outflow
|
COPPENS, M.
|
|
2007
|
5 |
7 |
p. 1556-1567
|
artikel
|
| 19 |
Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E2 biosynthesis in vascular smooth muscle cells
|
CAMACHO, M.
|
|
2007
|
5 |
7 |
p. 1411-1419
|
artikel
|
| 20 |
Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia
|
ZHENG, X.
|
|
2007
|
5 |
7 |
p. 1394-1400
|
artikel
|
| 21 |
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations
|
COPPENS, M.
|
|
2007
|
5 |
7 |
p. 1444-1448
|
artikel
|
| 22 |
Platelet integrin αIIbβ3: activation mechanisms
|
MA, Y.-Q.
|
|
2007
|
5 |
7 |
p. 1345-1352
|
artikel
|
| 23 |
Platelets express three different splice variants of ApoER2 that are all involved in signaling
|
PENNINGS, M. T. T.
|
|
2007
|
5 |
7 |
p. 1538-1544
|
artikel
|
| 24 |
Preserving vascular prostacyclin levels by microsomal prostaglandin E2 synthase isoform 1 inhibition: a new strategy for vasoprotection?
|
KRÖTZ, F.
|
|
2007
|
5 |
7 |
p. 1409-1410
|
artikel
|
| 25 |
Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia
|
POUPLARD, C.
|
|
2007
|
5 |
7 |
p. 1373-1379
|
artikel
|
| 26 |
Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator
|
HAYASHI, T.
|
|
2007
|
5 |
7 |
p. 1477-1485
|
artikel
|
| 27 |
Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα
|
MARTIN, C.
|
|
2007
|
5 |
7 |
p. 1363-1370
|
artikel
|
| 28 |
Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis
|
PRANDONI, P.
|
|
2007
|
5 |
7 |
p. 1555
|
artikel
|
| 29 |
Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice
|
EREN, M.
|
|
2007
|
5 |
7 |
p. 1500-1508
|
artikel
|
| 30 |
Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapy
|
ALTMAN, R.
|
|
2007
|
5 |
7 |
p. 1552-1569
|
artikel
|
| 31 |
TALKING ABOUT…
|
BRUTTOMESSO, G.
|
|
2007
|
5 |
7 |
p. 1570-1572
|
artikel
|
| 32 |
Testing for heparin-induced thrombocytopenia: are we there yet?
|
ARNOLD, D. M.
|
|
2007
|
5 |
7 |
p. 1371-1372
|
artikel
|
| 33 |
The critical role of myosin IIA in platelet internal contraction
|
JOHNSON, G. J.
|
|
2007
|
5 |
7 |
p. 1516-1529
|
artikel
|
| 34 |
The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite
|
SUGIDACHI, A.
|
|
2007
|
5 |
7 |
p. 1545-1551
|
artikel
|
| 35 |
Tissue factor around dermal vessels has bound factor VII in the absence of injury
|
HOFFMAN, M.
|
|
2007
|
5 |
7 |
p. 1403-1408
|
artikel
|
| 36 |
Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A
|
GOUW, S. C.
|
|
2007
|
5 |
7 |
p. 1383-1390
|
artikel
|
| 37 |
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study
|
SCHELLONG, S. M.
|
|
2007
|
5 |
7 |
p. 1431-1437
|
artikel
|
| 38 |
von Willebrand factor A1 domain: stuck in the middle
|
LENTING, P. J.
|
|
2007
|
5 |
7 |
p. 1361-1362
|
artikel
|
| 39 |
von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery
|
LETHAGEN, S.
|
|
2007
|
5 |
7 |
p. 1420-1430
|
artikel
|
| 40 |
What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population
|
SANTAMARÍA, A.
|
|
2007
|
5 |
7 |
p. 1565-1566
|
artikel
|
Tijdschrift beschrijving